FDA Inspection
Novartis Pharma Stein AGNovartis Pharma Stein AG – FDA Inspection, Aug 24, 2017
Record Details
This FDA Inspection record concerns Novartis Pharma Stein AG, with an inspection on August 24, 2017, issued by the Office of Inspections and Investigations, covering biologics.
View Company Profile
ID · f7f14324-13d3-44e9-802f-d55ecc1beaae
Inspection Facts
- Inspection number
- 1025563
- FDA center
- Biologics
- Outcome
- Form 483 issued
Other FDA inspections of Novartis Pharma Stein AG
13| Date | Classification | Office | Project area |
|---|---|---|---|
| May 19, 2026 | Not classified | Office of Inspections and Investigations | Human Cellular, Tissue, and Gene Therapies |
| November 20, 2023 | Not classified | Office of Inspections and Investigations | |
| December 6, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 4, 2018 | VAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| September 21, 2018 | Not classified | Office of Inspections and Investigations |
Other documents for Novartis Pharma Stein AG
- FDA Inspection 1319902 - 2026-05-19
- FDA Inspection 1230809 - 2023-11-20
- FDA Inspection 1192104 - 2022-12-06
- FDA Inspection 1073408 - 2018-12-04
- FDA Inspection 1071638 - 2018-09-21
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.